Citations

Citations to this article as recorded by  

• ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries
  Alaa El-Hussuna, Almuthe Christina Hauer, Tarkan Karakan, Valerie Pittet, Henit Yanai, Jalpa Devi, Jesus K Yamamoto-Furusho, Ali Reza Sima, Hailemichael Desalegn, Mutaz Idrees Sultan, Vishal Sharma, Hany Shehab, Lamya Mrabti, Natalia Queiroz, Anuraag Jena
  Journal of Crohn’s and Colitis.2026;[Epub]     CrossRef
• Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
  Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Ju
  Intestinal Research.2025; 23(1): 37.     CrossRef
• Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
  Arshdeep Singh, Ajit Sood
  Indian Journal of Gastroenterology.2025;[Epub]     CrossRef
• Practices and perceptions of 5-aminosalicylic acid use in Crohn’s disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team
  June Hwa Bae, Seung Yong Shin, Dong Hyun Kim, Seung Min Hong, Eun Mi Song, Ji Eun Kim, Young Joo Yang, Jiyoung Yoon, Sang-Bum Kang, Eun Soo Kim, Sung Eun Kim, Seong-Jung Kim, Jun Lee, Soo-Young Na, Soo Jung Park, Sang Hyoung Park, Won Moon, Sung-Ae Jung
  Intestinal Research.2025; 23(4): 491.     CrossRef
• Synthesis and Evaluation of Novel 5-{[2-Cyano-3-(substituted phenyl)prop-2-enoyl]amino}-2-hydroxy Benzoic Acid
  Ch. Soujanya, K. Madhavi
  Asian Journal of Chemistry.2025; 37(12): 3191.     CrossRef
• Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis
  Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Ramandeep Kaur, Shreya Garg, Kirti Arora, Namita Bansal, Ajit Sood
  Digestive Diseases and Sciences.2024; 69(4): 1389.     CrossRef
• The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis
  Huanhuan Chen, Huimin Wang, XiaoJing Xu, Ya'nan Hu, Jing Su, Dongdong Li, Zimu Li, Shixiang Feng, Jinming Liu, Huanxiang Zhang, Xiaoyan Wang
  International Immunopharmacology.2024; 134: 112255.     CrossRef
• The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
  Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
  Intestinal Research.2023; 21(1): 161.     CrossRef
• Development of Novel pH-Sensitive Eudragit Coated Beads Containing Curcumin-Mesalamine Combination for Colon-Specific Drug Delivery
  Eman J. Heikal, Rashad M. Kaoud, Shadeed Gad, Hatem I. Mokhtar, Abdullah Alattar, Reem Alshaman, Sawsan A. Zaitone, Yasser M. Moustafa, Taha M. Hammady
  Gels.2023; 9(4): 264.     CrossRef
• Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica
  José Fernando Vera Chamorro, Claudia Sánchez Franco, Melquicedec Vargas Sandoval, Diana Victoria Mora Quintero, Juan Pablo Riveros López, Fernando Sarmiento Quintero, Catalina Ortiz-Piedrahita, Otto Gerardo Calderón-Guerrero, Hugo Laignelet, Claudia Lili
  Revista colombiana de Gastroenterología.2023; 38(Supl No. 1): 1.     CrossRef
• Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea
  Sang Hyoung Park, Jong Pil Im, Hyunju Park, Seung Kyu Jeong, Ji Hyun Lee, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Joo Sung Kim, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O
  Journal of Crohn's and Colitis.2022; 16(2): 207.     CrossRef
• Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment
  Nuan Wen, Na Zhao, Huixian Xu, Ying Zhao, Jian Ma
  Irish Journal of Medical Science (1971 -).2022; 191(5): 2105.     CrossRef
• 5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
  Hyo Yeop Song, Geom Seog Seo
  The Korean Journal of Gastroenterology.2022; 79(1): 31.     CrossRef
• The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis
  Eun Ae Kang
  Gut and Liver.2022; 16(3): 487.     CrossRef
• Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
  Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2022; 37(5): 895.     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef